Medications for Aspergillosis
11 results
Itraconazole (itraconazole)
(Itraconazole)REMEDYREPACK INC.
Usage: Itraconazole capsules are indicated for treating fungal infections such as blastomycosis, histoplasmosis, and aspergillosis in both immunocompromised and non-immunocompromised patients. It is also used for onychomycosis of the toenail and fingernail due to dermatophytes in non-immunocompromised patients.
Itraconazole (itraconazole)
(ITRACONAZOLE)Accord Healthcare Inc.
Usage: Itraconazole capsules are indicated for treating pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis (in patients intolerant to amphotericin B), and onychomycosis of the toenail and fingernail due to dermatophytes in both immunocompromised and non-immunocompromised patients.
Posaconazole (posaconazole)
(posaconazole)Par Pharmaceutical Inc.
Usage: Posaconazole delayed-release tablets are indicated for treating invasive aspergillosis in patients aged 13 and older. It also prophylaxes invasive Aspergillus and Candida infections in severely immunocompromised patients. The oral suspension is approved for treating oropharyngeal candidiasis, including cases resistant to itraconazole or fluconazole in patients 13 and older.
Posaconazole (posaconazole)
(POSACONAZOLE)Camber Pharmaceuticals, Inc.
Usage: Posaconazole is indicated for the prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients, such as those with graft-versus-host disease after hematopoietic stem cell transplant or prolonged neutropenia due to chemotherapy. It is approved for adults and pediatric patients aged 2 years and older.
Posaconazole (posaconazole)
(POSACONAZOLE)Major Pharmaceuticals
Usage: Posaconazole delayed-release tablets are indicated for prophylaxis against invasive Aspergillus and Candida infections in severely immunocompromised patients, such as those undergoing hematopoietic stem cell transplantation with graft-versus-host disease or individuals with hematologic malignancies and prolonged neutropenia from chemotherapy.
Posaconazole (posaconazole)
(Posaconazole)NorthStar RxLLC
Usage: Posaconazole is indicated for the prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients, such as those undergoing hematopoietic stem cell transplants or chemotherapy-induced neutropenia. It is approved for adults and pediatric patients aged 13 years and older.
Posaconazole (posaconazole)
(posaconazole)Hikma Pharmaceuticals USA Inc.
Usage: Posaconazole is indicated for the prophylaxis of invasive Aspergillus and Candida infections in high-risk immunocompromised patients, and for the treatment of oropharyngeal candidiasis, including cases refractory to itraconazole or fluconazole, in adults and pediatric patients 13 years and older.
Posaconazole (posaconazole)
(posaconazole)Mylan Institutional LLC
Usage: Posaconazole injection is indicated for treating invasive aspergillosis in patients aged 13 and older and for prophylaxis against invasive Aspergillus and Candida infections in severely immunocompromised patients, including those with graft-versus-host disease or prolonged neutropenia from chemotherapy, starting at age 2.
Posaconazole (posaconazole)
(posaconazole)Novadoz Pharmaceuticals LLC
Usage: Posaconazole delayed-release tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients, including HSCT recipients with graft-versus-host disease and those with prolonged neutropenia from chemotherapy. It is suitable for adults and pediatric patients aged 2 years and older weighing over 40 kg.
Sporanox (itraconazole)
(ITRACONAZOLE)Janssen Pharmaceuticals, Inc.
Usage: SPORANOX (itraconazole) capsules are indicated for treating fungal infections in both immunocompromised and non-immunocompromised patients, including blastomycosis, histoplasmosis, and aspergillosis. It is also used for onychomycosis of toenails and fingernails due to dermatophytes in non-immunocompromised patients.